Current trends and challenges in the postoperative medical management of Crohn's disease: A systematic review
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Faculty Advisor
Karim AlaviDocument Type
Journal ArticlePublication Date
2017-11-01Keywords
Digestive System DiseasesGastroenterology
Health Services Administration
Medical Education
Surgery
Surgical Procedures, Operative
Metadata
Show full item recordAbstract
BACKGROUND: Crohn's disease is an aggressive chronic inflammatory disorder, and despite medical advances no cure exists. There is a great risk of requiring an operative intervention, with evidence of recurrence developing in up to 80-90% of cases. Therefore, we sought to systematically review the current status in the postoperative medical management of Crohn's disease. DATA SOURCES: A systematic literature review of medications administered following respective therapy for Crohn's disease was performed from 1979 through 2016. Twenty-six prospective articles provided directed guidelines for recommendations and these were graded based on the level of evidence. CONCLUSIONS: The postoperative management of Crohn's disease faces multiple challenges. Current indicated medications in this setting include: antibiotics, aminosalicylates, immunomodulators, and biologics. Each drug has inherent risks and benefits, and the optimal regimen is still unknown. Initiating therapy in a prophylactic fashion compared to endoscopic findings, or escalating therapy versus treating with the most potent drug first is debated. Although a definitive consensus on postoperative treatment is necessary, aggressive and early endoluminal surveillance is paramount in the treatment of these complicated patients.Source
Am J Surg. 2017 Nov;214(5):931-937. doi: 10.1016/j.amjsurg.2017.04.016. Epub 2017 Jun 6. Link to article on publisher's site
DOI
10.1016/j.amjsurg.2017.04.016Permanent Link to this Item
http://hdl.handle.net/20.500.14038/49330PubMed ID
28666580Notes
Nicole B. Cherng participated in this study as a medical student as part of the Senior Scholars research program at the University of Massachusetts Medical School.
Related Resources
ae974a485f413a2113503eed53cd6c53
10.1016/j.amjsurg.2017.04.016